JP2024520556A5 - - Google Patents

Info

Publication number
JP2024520556A5
JP2024520556A5 JP2023573589A JP2023573589A JP2024520556A5 JP 2024520556 A5 JP2024520556 A5 JP 2024520556A5 JP 2023573589 A JP2023573589 A JP 2023573589A JP 2023573589 A JP2023573589 A JP 2023573589A JP 2024520556 A5 JP2024520556 A5 JP 2024520556A5
Authority
JP
Japan
Prior art keywords
sddna
group
modified
molecule according
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023573589A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024520556A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/031666 external-priority patent/WO2022256354A1/en
Publication of JP2024520556A publication Critical patent/JP2024520556A/ja
Publication of JP2024520556A5 publication Critical patent/JP2024520556A5/ja
Pending legal-status Critical Current

Links

JP2023573589A 2021-05-29 2022-05-31 新規遺伝子サイレンシング技術としての短鎖二重鎖dnaおよびその使用 Pending JP2024520556A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163195010P 2021-05-29 2021-05-29
US63/195,010 2021-05-29
PCT/US2022/031666 WO2022256354A1 (en) 2021-05-29 2022-05-31 Short duplex dna as a novel gene silencing technology and use thereof

Publications (2)

Publication Number Publication Date
JP2024520556A JP2024520556A (ja) 2024-05-24
JP2024520556A5 true JP2024520556A5 (cg-RX-API-DMAC10.html) 2025-06-10

Family

ID=82358463

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023573589A Pending JP2024520556A (ja) 2021-05-29 2022-05-31 新規遺伝子サイレンシング技術としての短鎖二重鎖dnaおよびその使用

Country Status (9)

Country Link
US (1) US20240254490A1 (cg-RX-API-DMAC10.html)
EP (1) EP4347828A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024520556A (cg-RX-API-DMAC10.html)
KR (1) KR20240014533A (cg-RX-API-DMAC10.html)
CN (1) CN118369428A (cg-RX-API-DMAC10.html)
AU (1) AU2022286925A1 (cg-RX-API-DMAC10.html)
CA (1) CA3221923A1 (cg-RX-API-DMAC10.html)
TW (1) TW202313977A (cg-RX-API-DMAC10.html)
WO (1) WO2022256354A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024298074A1 (en) * 2023-07-21 2026-02-19 Bisirna Therapeutics Pte. Ltd. Double-stranded oligonucleotide agents and uses thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100523215C (zh) 2000-12-01 2009-08-05 马普科技促进协会 介导rna干涉的小rna分子
US7074824B2 (en) 2001-07-31 2006-07-11 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
US6962944B2 (en) 2001-07-31 2005-11-08 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
CA2504694C (en) 2002-11-05 2013-10-01 Isis Pharmaceuticals, Inc. Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
DK1661905T3 (da) 2003-08-28 2012-07-23 Takeshi Imanishi Hidtil ukendte syntetiske nukleinsyrer af N-O-krydsbindingstype
WO2005027962A1 (en) 2003-09-18 2005-03-31 Isis Pharmaceuticals, Inc. 4’-thionucleosides and oligomeric compounds
EP1799859B1 (en) 2004-09-17 2014-07-02 Isis Pharmaceuticals, Inc. Enhanced antisense oligonucleotides
DE602007009487D1 (de) 2006-01-27 2010-11-11 Isis Pharmaceutical Inc 6-modifizierte bicyclische nukleinsäureanaloga
EP2505646A1 (en) 2006-05-05 2012-10-03 Isis Pharmaceuticals, Inc. Compounds and methods for modulating expression of CRP
CA2651453C (en) 2006-05-11 2014-10-14 Isis Pharmaceuticals, Inc. 5'-modified bicyclic nucleic acid analogs
MX2009003398A (es) * 2006-09-27 2009-08-12 Coley Pharm Gmbh Analogos de oligonucleotidos cpg que contienen analogos t hidrofobos con actividad inmunoestimuladora mejorada.
US20100190837A1 (en) 2007-02-15 2010-07-29 Isis Pharmaceuticals, Inc. 5'-Substituted-2-F' Modified Nucleosides and Oligomeric Compounds Prepared Therefrom
DK2170917T3 (da) 2007-05-30 2012-10-08 Isis Pharmaceuticals Inc N-Substituerede bicycliske nukleinsyreanaloge med aminomethylenbro
WO2008154401A2 (en) 2007-06-08 2008-12-18 Isis Pharmaceuticals, Inc. Carbocyclic bicyclic nucleic acid analogs
AU2008272918B2 (en) 2007-07-05 2012-09-13 Isis Pharmaceuticals, Inc. 6-disubstituted bicyclic nucleic acid analogs
EP3121281B1 (en) 2007-08-27 2021-03-31 1Globe Health Institute LLC Compositions of asymmetric interfering rna and uses thereof
JP6472087B2 (ja) * 2013-05-30 2019-02-27 国立大学法人 東京医科歯科大学 治療用オリゴヌクレオチドを送達するための二本鎖剤
JPWO2017068790A1 (ja) * 2015-10-23 2018-08-09 レナセラピューティクス株式会社 核酸複合体
US11260134B2 (en) * 2016-09-29 2022-03-01 National University Corporation Tokyo Medical And Dental University Double-stranded nucleic acid complex having overhang

Similar Documents

Publication Publication Date Title
EP3647318B1 (en) Linkage modified oligomeric compounds
CN105121452A (zh) 三环核苷和由其制备的寡聚化合物
TW201819397A (zh) 減少atxn3表現之化合物及方法
KR20200024793A (ko) 알파-ENaC의 발현을 억제하기 위한 RNAi 작용제 및 사용 방법
EP4463553B1 (en) Advanced rna targeting (arnatar)
CN111902537A (zh) Dnm2表达的调节剂
JP2024520555A5 (cg-RX-API-DMAC10.html)
CN104321334A (zh) 三环核苷及由其制备的低聚化合物
EP4671372A2 (en) Translation-enhancing nucleic acid compounds: Upward regulation 1 coupled with ASO (ACT-UP1) and their uses
WO2024040041A1 (en) Regulation of activity of rnai molecules
TW202309286A (zh) 作為新穎基因靜默技術的非對稱短雙股dna及其應用
JP7128517B2 (ja) 副作用を減じたアンチセンス核酸
Pontarelli et al. Arabinonucleic acids containing C5-propynyl modifications form stable hybrid duplexes with RNA that are efficiently degraded by E. coli RNase H
US20240336920A1 (en) Threose nucleic acid antisense oligonucleotides and methods thereof
TW202313977A (zh) 作為新穎基因靜默技術的短雙股dna及其應用
JP2025542580A (ja) 遺伝子サイレンシング技術としての、デオキシリボヌクレオチドが散在している短鎖二重鎖rna、およびその使用
JP7216381B2 (ja) Rna作用抑制剤及びその利用
HK40108297A (en) Short duplex dna as a novel gene silencing technology and use thereof
HK40110327A (en) Asymmetric short duplex dna as a novel gene silencing technology and use thereof
HK40129500A (en) Translation enhancing nucleic acid compounds: aso coupled translation - upregulation 1 (act-up1) and uses thereof
JP2025542579A (ja) 遺伝子サイレンシング技術としての、デオキシリボヌクレオチドが散在している非対称短鎖二重鎖rna、およびその使用
CN120676949A (zh) 反义RNA(asRNA)技术及其应用
HK40128552A (en) Advanced rna targeting (arnatar)
HK40111629A (en) Threose nucleic acid antisense oligonucleotides and methods thereof
CN121002043A (zh) 环状反义核酸疗法